MAPK8 and prostate cancer: Overall these results suggested that the OA inhibited ERK/AKT/JNK pathway in DU145 xenografted tumors and that the inhibition of this pathway could induce cell cycle arrest, suppresses tumor cell proliferation, and prostate cancer growth.